Identification of Spiro-Fused [3-azabicyclo[3.1.0]hexane]oxindoles as Potential Antitumor Agents: Initial In Vitro Evaluation of Anti-Proliferative Effect and Actin Cytoskeleton Transformation in 3T3 and 3T3-SV40 Fibroblast

Novel heterocyclic compounds containing 3-spiro[3-azabicyclo[3.1.0]hexane]oxindole framework (<b>4a</b>, <b>4b</b> and <b>4c</b>) have been studied as potential antitumor agents. The in silico ADMET (adsorption, distribution, metabolism, excretion and toxicity) an...

Full description

Bibliographic Details
Main Authors: Nickolay A. Knyazev, Stanislav V. Shmakov, Sofya A. Pechkovskaya, Alexander S. Filatov, Alexander V. Stepakov, Vitali M. Boitsov, Natalia A. Filatova
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:International Journal of Molecular Sciences
Subjects:
3T3
Online Access:https://www.mdpi.com/1422-0067/22/15/8264
id doaj-70f26799e12742a3a33ec0284ecce78a
record_format Article
spelling doaj-70f26799e12742a3a33ec0284ecce78a2021-08-06T15:26:05ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-07-01228264826410.3390/ijms22158264Identification of Spiro-Fused [3-azabicyclo[3.1.0]hexane]oxindoles as Potential Antitumor Agents: Initial In Vitro Evaluation of Anti-Proliferative Effect and Actin Cytoskeleton Transformation in 3T3 and 3T3-SV40 FibroblastNickolay A. Knyazev0Stanislav V. Shmakov1Sofya A. Pechkovskaya2Alexander S. Filatov3Alexander V. Stepakov4Vitali M. Boitsov5Natalia A. Filatova6Saint-Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological), 197758 Saint Petersburg, RussiaSaint Petersburg National Research Academic University of the Russian Academy of Sciences, 194021 Saint Petersburg, RussiaInstitute of Cytology, Russian Academy of Sciences, 194064 Saint Petersburg, RussiaDepartment of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, RussiaDepartment of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, RussiaSaint Petersburg National Research Academic University of the Russian Academy of Sciences, 194021 Saint Petersburg, RussiaInstitute of Cytology, Russian Academy of Sciences, 194064 Saint Petersburg, RussiaNovel heterocyclic compounds containing 3-spiro[3-azabicyclo[3.1.0]hexane]oxindole framework (<b>4a</b>, <b>4b</b> and <b>4c</b>) have been studied as potential antitumor agents. The in silico ADMET (adsorption, distribution, metabolism, excretion and toxicity) analysis was performed on <b>4a</b>–<b>c</b> compounds with promising antiproliferative activity, previously synthetized and screened against human erythroleukemic cell line K562 tumor cell line. Cytotoxicity of <b>4a</b>–<b>c</b> against murine fibroblast 3T3 and SV-40 transformed murine fibroblast 3T3-SV40 cell lines were evaluated. The <b>4a</b> and <b>4c</b> compounds were cytotoxic against 3T3-SV40 cells in comparison with those of 3T3. In agreement with the DNA cytometry studies, the tested compounds have achieved significant cell-cycle perturbation with higher accumulation of cells in G0/G1 phase. Using confocal microscopy, we found that with <b>4a</b> and <b>4c</b> treatment of 3T3 cells, actin filaments disappeared, and granular actin was distributed diffusely in the cytoplasm in 82–97% of cells. The number of 3T3-SV40 cells with stress fibers increased to 7–30% against 2% in control. We discovered that transformed 3T3-SV40 cells after treatment with compounds <b>4a</b> and <b>4c</b> significantly reduced the number of cells with filopodium-like membrane protrusions (from 86 % in control cells to 6–18% after treatment), which indirectly suggests a decrease in cell motility. We can conclude that the studied compounds <b>4a</b> and <b>4c</b> have a cytostatic effect, which can lead to a decrease in the number of filopodium-like membrane protrusions.https://www.mdpi.com/1422-0067/22/15/8264actinmetastasis3T33T3-SV403-spiro[azabicyclo[3.1.0]hexane]oxindolestumor cells
collection DOAJ
language English
format Article
sources DOAJ
author Nickolay A. Knyazev
Stanislav V. Shmakov
Sofya A. Pechkovskaya
Alexander S. Filatov
Alexander V. Stepakov
Vitali M. Boitsov
Natalia A. Filatova
spellingShingle Nickolay A. Knyazev
Stanislav V. Shmakov
Sofya A. Pechkovskaya
Alexander S. Filatov
Alexander V. Stepakov
Vitali M. Boitsov
Natalia A. Filatova
Identification of Spiro-Fused [3-azabicyclo[3.1.0]hexane]oxindoles as Potential Antitumor Agents: Initial In Vitro Evaluation of Anti-Proliferative Effect and Actin Cytoskeleton Transformation in 3T3 and 3T3-SV40 Fibroblast
International Journal of Molecular Sciences
actin
metastasis
3T3
3T3-SV40
3-spiro[azabicyclo[3.1.0]hexane]oxindoles
tumor cells
author_facet Nickolay A. Knyazev
Stanislav V. Shmakov
Sofya A. Pechkovskaya
Alexander S. Filatov
Alexander V. Stepakov
Vitali M. Boitsov
Natalia A. Filatova
author_sort Nickolay A. Knyazev
title Identification of Spiro-Fused [3-azabicyclo[3.1.0]hexane]oxindoles as Potential Antitumor Agents: Initial In Vitro Evaluation of Anti-Proliferative Effect and Actin Cytoskeleton Transformation in 3T3 and 3T3-SV40 Fibroblast
title_short Identification of Spiro-Fused [3-azabicyclo[3.1.0]hexane]oxindoles as Potential Antitumor Agents: Initial In Vitro Evaluation of Anti-Proliferative Effect and Actin Cytoskeleton Transformation in 3T3 and 3T3-SV40 Fibroblast
title_full Identification of Spiro-Fused [3-azabicyclo[3.1.0]hexane]oxindoles as Potential Antitumor Agents: Initial In Vitro Evaluation of Anti-Proliferative Effect and Actin Cytoskeleton Transformation in 3T3 and 3T3-SV40 Fibroblast
title_fullStr Identification of Spiro-Fused [3-azabicyclo[3.1.0]hexane]oxindoles as Potential Antitumor Agents: Initial In Vitro Evaluation of Anti-Proliferative Effect and Actin Cytoskeleton Transformation in 3T3 and 3T3-SV40 Fibroblast
title_full_unstemmed Identification of Spiro-Fused [3-azabicyclo[3.1.0]hexane]oxindoles as Potential Antitumor Agents: Initial In Vitro Evaluation of Anti-Proliferative Effect and Actin Cytoskeleton Transformation in 3T3 and 3T3-SV40 Fibroblast
title_sort identification of spiro-fused [3-azabicyclo[3.1.0]hexane]oxindoles as potential antitumor agents: initial in vitro evaluation of anti-proliferative effect and actin cytoskeleton transformation in 3t3 and 3t3-sv40 fibroblast
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-07-01
description Novel heterocyclic compounds containing 3-spiro[3-azabicyclo[3.1.0]hexane]oxindole framework (<b>4a</b>, <b>4b</b> and <b>4c</b>) have been studied as potential antitumor agents. The in silico ADMET (adsorption, distribution, metabolism, excretion and toxicity) analysis was performed on <b>4a</b>–<b>c</b> compounds with promising antiproliferative activity, previously synthetized and screened against human erythroleukemic cell line K562 tumor cell line. Cytotoxicity of <b>4a</b>–<b>c</b> against murine fibroblast 3T3 and SV-40 transformed murine fibroblast 3T3-SV40 cell lines were evaluated. The <b>4a</b> and <b>4c</b> compounds were cytotoxic against 3T3-SV40 cells in comparison with those of 3T3. In agreement with the DNA cytometry studies, the tested compounds have achieved significant cell-cycle perturbation with higher accumulation of cells in G0/G1 phase. Using confocal microscopy, we found that with <b>4a</b> and <b>4c</b> treatment of 3T3 cells, actin filaments disappeared, and granular actin was distributed diffusely in the cytoplasm in 82–97% of cells. The number of 3T3-SV40 cells with stress fibers increased to 7–30% against 2% in control. We discovered that transformed 3T3-SV40 cells after treatment with compounds <b>4a</b> and <b>4c</b> significantly reduced the number of cells with filopodium-like membrane protrusions (from 86 % in control cells to 6–18% after treatment), which indirectly suggests a decrease in cell motility. We can conclude that the studied compounds <b>4a</b> and <b>4c</b> have a cytostatic effect, which can lead to a decrease in the number of filopodium-like membrane protrusions.
topic actin
metastasis
3T3
3T3-SV40
3-spiro[azabicyclo[3.1.0]hexane]oxindoles
tumor cells
url https://www.mdpi.com/1422-0067/22/15/8264
work_keys_str_mv AT nickolayaknyazev identificationofspirofused3azabicyclo310hexaneoxindolesaspotentialantitumoragentsinitialinvitroevaluationofantiproliferativeeffectandactincytoskeletontransformationin3t3and3t3sv40fibroblast
AT stanislavvshmakov identificationofspirofused3azabicyclo310hexaneoxindolesaspotentialantitumoragentsinitialinvitroevaluationofantiproliferativeeffectandactincytoskeletontransformationin3t3and3t3sv40fibroblast
AT sofyaapechkovskaya identificationofspirofused3azabicyclo310hexaneoxindolesaspotentialantitumoragentsinitialinvitroevaluationofantiproliferativeeffectandactincytoskeletontransformationin3t3and3t3sv40fibroblast
AT alexandersfilatov identificationofspirofused3azabicyclo310hexaneoxindolesaspotentialantitumoragentsinitialinvitroevaluationofantiproliferativeeffectandactincytoskeletontransformationin3t3and3t3sv40fibroblast
AT alexandervstepakov identificationofspirofused3azabicyclo310hexaneoxindolesaspotentialantitumoragentsinitialinvitroevaluationofantiproliferativeeffectandactincytoskeletontransformationin3t3and3t3sv40fibroblast
AT vitalimboitsov identificationofspirofused3azabicyclo310hexaneoxindolesaspotentialantitumoragentsinitialinvitroevaluationofantiproliferativeeffectandactincytoskeletontransformationin3t3and3t3sv40fibroblast
AT nataliaafilatova identificationofspirofused3azabicyclo310hexaneoxindolesaspotentialantitumoragentsinitialinvitroevaluationofantiproliferativeeffectandactincytoskeletontransformationin3t3and3t3sv40fibroblast
_version_ 1721218271664930816